MSD
UK government drops Cervarix for Gardasil
November 28, 2011Sales and Marketing Cervarix, GSK, Gardasil, MSD, Sanofi
The UK government has performed a U-turn on its HPV vaccine programme by favouring Sanofi and MSD’s Gardasil over GlaxoSmithKline’s …
Merck’s COPD drug rejected by NICE
September 15, 2011Sales and Marketing Daxas, MSD, Merck & Co, NICE, roflumilast
NICE has not recommended Merck Co’s Daxas and has advised the firm to conduct a clinical trial in order to …
MSD’s Deepak Khanna to chair American Pharmaceutical Group
March 17, 2011Research and Development, Sales and Marketing American Pharmaceutical Group, Deepak Khanna, MSD, merck sharp and dohme
Merck Sharp and Dohme’s UK managing director Deepak Khanna has been appointed chairman of the American Pharmaceutical Group. The APG …
Pharma-NHS diabetes project begins
February 9, 2011Sales and Marketing AstraZeneca, Lilly UK, MSD, NHS, Nottingham, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, joint working
A joint venture between the NHS, charities and the pharma sector has begun in Nottingham to help treat the city’s …
Working Life: Merck Sharp & Dohme medical director Paul Robinson
February 4, 2011Business Services, Research and Development MSD, Paul Robinson, Working Life, careers, merck sharp and dohme, recruitment
Paul Robinson, medical director at Merck Sharp & Dohme, looks at how his field is changing, the most enjoyable things …
MSD launches asthma training resources
August 6, 2010Medical Communications, Sales and Marketing MSD, asthma, medical education, merck sharp and dohme, nurses
A new training resource aimed at helping primary care nurses manage asthma has been launched with funding from Merck Sharp …
Merck appoints UK leadership team
January 26, 2010MSD, Merck & Co, appointment
Merck & Co’s UK business has unveiled its new leadership team, following last year’s merger with Schering-Plough. Merck Sharp & …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
